http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0658555-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bd433e19d43c4d9b2a68ed8443b9a9a |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-22 |
filingDate | 1994-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc6c045649ceb4a8ea3a06a0e4c54af5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f571ba979baacbdb86d0fe75da5304ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e5d90a888fb20b0f9368da7a9ff4758 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f659f4e54df2c497e7bcfb3928dcfa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2644194f639313b6cb692ba1a8f053 |
publicationDate | 1995-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0658555-A1 |
titleOfInvention | Pyridazinone derivatives, processes for production thereof and use thereof |
abstract | Pyridazinone derivatives of formula (I):n n wherein R¹ represents a hydrogen atom or a methyl group which may be substituted with an aliphatic cyclic amino group optionally containing a hetero atom in the ring thereof; each of X¹ and X² independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a cyano group, a nitro group or a group shown by - CO-NR²R³ (wherein each of R² and R³ independently represents an alkyl group having 1 to 6 carbon atoms); Y represents a halogen atom; Z represents an alkoxy group having 1 to 6 carbon atoms; ℓ represents 0 or an integer of 1 to 3; A represents CH or N; m represents 0 or an integer of 1 or 2; and n represents an integer of 1 to 8, exhibit a platelet aggregation inhibiting activity and are useful for the treatment of circulatory disorders such as cerebral infarction. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008069609-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0033845-A1 |
priorityDate | 1993-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.